Blog Standard

Introduction Since 2013, almost 170,000 AI-related patents have been filed globally, accounting for half of all AI-related patents ever filed1.  Unlike other major jurisdictions like Europe, Japan, and the US, India has not issued specific rules for examining inventions related to artificial intelligence. The Computer-Related Inventions Guidelines 2017 (CRI guidelines)2 are used to evaluate these […]

Introduction Biosimilars, a category of biologic medications, are offering new hope for patients by providing cost-effective alternatives to original biologics, which are often expensive and complex. Biosimilars are a type of biologic medication that is safe and effective for treating many illnesses. A biosimilar and its original biologic have the same treatment risks and benefits. […]

Introduction Polymorphs are compounds that can exist in two or more crystalline structures with the same chemical composition but different molecular arrangements. These variations result in differing physical properties such as solubility, and dissolution rates, making polymorphs especially important in industries like pharmaceuticals, agrochemicals, and pigments. For pharmaceutical companies, securing patents for polymorphs in addition […]

“The best way to predict the future is to invent it” – Alan Kay Introduction To get a patent over an invention, an inventor must apply for the patent as per the jurisdictional laws. In India, patents are governed by the Indian Patent Act, 1970 (hereinafter referred to as “Act”). Generally, every invention has its […]

Introduction In a significant ruling on design infringement, the Bombay High Court recently granted an ad-interim injunction to Pidilite Industries, effectively restraining Astral Limited from using containers that were found to be deceptively similar to Pidilite’s registered M-SEAL PV SEAL containers. This blog will delve into the details of the case, examining the court’s decision […]

Introduction On July 9, 2024, in F-Hoffmann-La Roche Ag & Anr v. Zydus Lifesciences Limited [1], the Delhi High Court issued a temporary injunction preventing Zydus Lifesciences from selling its breast cancer drug, Sigrima. This biosimilar of Roche’s Pertuzumab (marketed as Perjeta®) became the center of a patent infringement lawsuit initiated by Roche against Zydus […]

Introduction In a significant ruling on July 30, 2024, in Star Scientific Limited v. The Controller of Patents and Designs, the Delhi High Court overturned the decision of the Controller of Patents and Designs, which had refused the grant of a patent to Star Scientific Limited. The Court held that the mere non-attendance of a […]